Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001724521-25-000019
Filing Date
2025-01-27
Accepted
2025-01-27 16:30:42
Documents
1
Period of Report
2025-01-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1738013435.html 4  
1 FORM 4 wk-form4_1738013435.xml 4 5090
  Complete submission text file 0001724521-25-000019.txt   6509
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Issuer) CIK: 0001724521 (see all company filings)

EIN.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ARCUS BIOSCIENCES, INC. 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address
Ribas Antoni (Reporting) CIK: 0001792164 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38419 | Film No.: 25559459